Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
CC1C(=NC(=NC=1N)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(=O)N[C@@H](C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)C1=CNC=N1)C(=O)N[C@@H](C)[C@H](O)[C@@H](C)C(=O)N[C@H]([C@@H](C)O)C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C
18)11-6-4-10(9-15)5-7-11/h4-7
Narasin has been shown to induce tumor necrosis factor-related apoptosis-induced ligand (TRAIL)-mediated apoptosis by ER stress in glioma cells and to dampen NF-κB signaling by suppressing the phosphorylation of IκBα
PCI-27483 Catalog No.:M25013-C Ceftaroline fosamil for the treatmentPCI 27483 is a FVIIa tissue factor inhibitor, with antitumour effects. Product information CAS Number: 871266 63 6 Molecular Weight: 596. 57 Formula: C26H24N6O9S Chemical Name: (2S) 2 {2 [5 (6 carbamimidoyl 1H 1,3 benzodiazol 2 yl) 2',6 dihydroxy 5' sulfamoyl [1,1' biphenyl] 3 yl]acetamido}butanedioic acid Smiles: NC(=N)C1=CC2NC(=NC=2C=C1)C1=CC(CC(=O)N[C@@H](CC(O)=O)C(O)=O)=CC(C2=CC(=CC=C2O)S(N)(=O)=O)=C1O InChiKey: WDJHHCAKBRKCLW IBGZPJMESA N InChi:
US$ 827.00
US$ 429.00
US$ 872.00
US$ 3036.50
US$ 540.00
US$ 1459.50
US$ 2897.00
US$ 1111.50
US$ 1279.50
US$ 4018.00
US$ 137.68
US$ 861.00
US$ 578.50
US$ 1055.50
US$ 2275.00
Sold : Login>>